Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 21,078 shares at $57.45 ($1.2M) on 2024-02-20, disclosed to the SEC on 2024-02-22.
Scheduled sale ($1.2M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.43 | 10,000 | $574K | 47.5% |
| 2 | $57.45 | 10,000 | $575K | 47.5% |
| 3 | $55.30 | 569 | $31K | 2.6% |
| 4 | $55.31 | 509 | $28K | 2.3% |
| Total | $57.33 avg | 21,078 | $1.2M | 100% |
| Filing → |
| MLTX | SELL | 2026-07-21 | $878K | — | Filing → |
| MLTX | SELL | 2026-07-20 | $322K | — | Filing → |
| MLTX | SELL | 2026-06-17 | $2.9M | — | Filing → |